Journal of the Korean Ophthalmological Society 2000;41(5):1151-1157.
Published online May 1, 2000.
Clinical Results in 1000 Cases of Acrysof Intraocular Lens Implantations.
Eun Jeong Jeon, Ki Bong Kim, Suk Woo Yang
Department of Ophthalmology, Our Lady of Mercy Hospital, College of Medicine, The Catholic University, Seoul, Korea.
아크리소프 인공수정체 1000 예 삽입후 임상결과
전은정(Eun Jeong Jeon),김기봉(Ki Bong Kim),양석우(Suk Woo Yang)
Abstract
To evaluate the clinical results of implantation of Acrysof foldable intraocular lens[IOL], we retrospectively analyzed 814 patients who had been implanted with Acrysof IOLs in their eyes and followed-up over 6months postoperatively. Postoperative conditions such as best corrected visual acuity[BCVA], postoperative complications and capsular fibrosis were evaluated. Postoperative BCVA, with measurement above 0.7 was 83%and above 0.5 was 92%.If there was no ocular pathology, BCVA with measurement above 0.7 was 96.5%.Postoperative complications included 9.8%[80 cases]of posterior capsular opacity, 3.2%[28 cases]of microvacuole, and also anterior capsule contracture, haptic damage.7 cases of posterior capsular opacity[totally 80 cases]required Nd;Yag laser posterior capsulotomy.Capsular fibrosis[61.8%]was divided to 4 grades.Most of them were grade I or IIand above grade was 9.8%. In conclusion, the Acrysof IOL implantation showed good visual outcome and few postoperative complications, especially in PCO, it had excellent results.So, it will show excellent longterm visual prognosis including visual quality.
Key Words: Acrysof IOL;Capsular fibrosis;Posterior capsular opacity


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next